Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PI3K in lymphocyte development, differentiation and activation.

Klaus Okkenhaug1, Bart Vanhaesebroeck

  • 1Molecular Immunology Programme, The Babraham Institute, Cambridge CB2 4AT, UK. klaus.okkenhaug@bbsrc.ac.uk

Nature Reviews. Immunology
|April 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A conserved VPS34-PIKfyve-TRPML1-myosin II axis regulates the speed of amoeboid cell migration.

EMBO reports·2026
Same author

From the gene to the clinic: Key milestones in the PI3Kδ journey.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Not just another kinase: the many roles of PI3K-δ in adaptive immunity.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

A renaissance in targeting the PI3K/AKT/mTOR pathway.

Nature reviews. Drug discovery·2026
Same author

Phosphoinositide 3-kinase δ activity in patients with systemic lupus erythematosus.

Frontiers in immunology·2026
Same author

A diabetes-induced change of MDM2 SNP309T→G contributes to aberrant retinal angiogenesis.

Diabetologia·2026

Phosphoinositide 3-kinases (PI3K) are crucial for immune cell function. Gene-targeting studies reveal specific PI3K subunits, like p110delta, are key to B and T cell signaling pathways.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Phosphoinositide 3-kinases (PI3Ks) are critical regulators of fundamental cellular processes, including growth, metabolism, and survival.
  • Dysregulated PI3K signaling is implicated in immune disorders such as immunodeficiency, autoimmunity, and certain leukemias.
  • Recent advancements have focused on understanding PI3K's specific roles within the immune system, particularly in lymphocytes.

Purpose of the Study:

  • To elucidate the specific roles of PI3K subunits in lymphocyte biology.
  • To identify the PI3K subunits involved in B-cell and T-cell receptor signaling.
  • To explore novel molecular interactions governing PI3K activation and downstream signaling pathways.

Main Methods:

  • Gene-targeting studies in relevant model systems.

Related Experiment Videos

  • Analysis of B-cell and T-cell signaling pathways.
  • Investigation of molecular interactions and protein complex formation.

    • Main Results:

    • Gene-targeting studies have identified key PI3K subunits essential for lymphocyte function.
    • The catalytic subunit p110delta is specifically adapted for transmitting antigen-receptor signals in both B and T cells.
    • New molecular interactions leading to PI3K activation and subsequent pathway regulation have been uncovered.

    Conclusions:

    • PI3K signaling is indispensable for normal lymphocyte function, with specific subunits playing critical roles.
    • The p110delta subunit is a pivotal component in antigen-receptor mediated signaling in lymphocytes.
    • Further research into PI3K activation mechanisms and pathways offers therapeutic potential for immune-related diseases.